Strides Pharma Science Limited (STAR.NS)
INR 701.9
(1.52%)
INR 701.9
(1.52%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Revenue | 40.51 Billion | 36.88 Billion | 30.22 Billion | 32.51 Billion | 26.56 Billion | 29.43 Billion |
| Cost of Revenue | 26.12 Billion | 16.26 Billion | 15.83 Billion | 14.08 Billion | 11.83 Billion | 15.04 Billion |
| Gross Profit | 14.38 Billion | 20.61 Billion | 14.38 Billion | 18.42 Billion | 14.72 Billion | 14.39 Billion |
| Operating Expenses | 9.16 Billion | 18.74 Billion | 16.8 Billion | 14.21 Billion | 11.06 Billion | 11.45 Billion |
| Selling, General and Administrative Expenses | 9.16 Billion | 4.11 Billion | 4.82 Billion | 3.38 Billion | 1.31 Billion | 1.66 Billion |
| Research and Development Expenses | - | 638.65 Million | 893.88 Million | 1.05 Billion | 1.03 Billion | 1.28 Billion |
| Other Expenses | - | 18.74 Billion | 11.98 Billion | 10.82 Billion | 9.74 Billion | 135.85 Million |
| Cost and Expenses | 35.28 Billion | 35.01 Billion | 32.63 Billion | 28.29 Billion | 22.9 Billion | 26.49 Billion |
| Operating Income | 5.22 Billion | -796.99 Million | -2.82 Billion | 4.56 Billion | 2.08 Billion | 2.94 Billion |
| Interest Expense | 3.14 Billion | 2.61 Billion | 1.45 Billion | 1.33 Billion | 304.25 Million | 1.69 Billion |
| Income Tax Expense | 315.9 Million | -553.01 Million | -1.78 Billion | 316.51 Million | 113.23 Million | 131.22 Million |
| Earnings before Tax | -1.16 Billion | -2.86 Billion | -6.52 Billion | 2.75 Billion | 546.8 Million | 720.55 Million |
| Net Income | -706.14 Million | -2.3 Billion | -4.74 Billion | 2.68 Billion | 363.91 Million | 3.24 Billion |
| Earnings Per Share Basic | -7.76 | -25.63 | -52.84 | 28.40 | 2.70 | 36.25 |
| Earnings Per Share Diluted | -7.75 | -25.63 | -52.84 | 28.37 | 2.70 | 36.24 |
| Weighted Average Shares Outstanding | 91 Million | 90.08 Million | 89.74 Million | 89.6 Million | 89.55 Million | 89.54 Million |
| Weighted Average Shares Outstanding (Diluted) | 91.12 Million | 90.08 Million | 89.74 Million | 89.7 Million | 89.58 Million | 89.57 Million |
| Gross Margin | 0.36 | 0.56 | 0.48 | 0.57 | 0.55 | 0.49 |
| EBIT Margin | 0.09 | 0.04 | -0.02 | 0.20 | 0.15 | 0.12 |
| Profit Margin | -0.02 | -0.06 | -0.16 | 0.08 | 0.01 | 0.11 |
| EBITDA | 3.76 Billion | 5.02 Billion | -1.34 Billion | 7.25 Billion | 4.86 Billion | 2.99 Billion |
| Earnings Before Tax Margin | 0.13 | -0.02 | -0.09 | 0.14 | 0.08 | 0.10 |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | 12.01 Billion | 10.87 Billion | 40.51 Billion | 10.84 Billion | 10.37 Billion | 9.99 Billion |
| Cost of Revenue | 4.97 Billion | 6.81 Billion | 26.12 Billion | 6.65 Billion | 4.21 Billion | 4.18 Billion |
| Gross Profit | 7.03 Billion | 4.06 Billion | 14.38 Billion | 4.18 Billion | 6.16 Billion | 5.81 Billion |
| Operating Expenses | 5.17 Billion | 2.37 Billion | 9.16 Billion | 2.38 Billion | 4.73 Billion | 4.88 Billion |
| Selling, General and Administrative Expenses | 2.47 Billion | 2.37 Billion | - | 2.38 Billion | 2.38 Billion | 2.28 Billion |
| Research and Development Expenses | - | - | - | - | - | - |
| Other Expenses | 5.17 Billion | 127.16 Million | 397.01 Million | -135.46 Million | 87.54 Million | 358.48 Million |
| Cost and Expenses | 10.15 Billion | 9.19 Billion | 35.28 Billion | 9.04 Billion | 8.95 Billion | 9.06 Billion |
| Operating Income | 1.85 Billion | 1.68 Billion | 5.22 Billion | 1.79 Billion | 1.07 Billion | 876.39 Million |
| Interest Expense | 821.49 Million | 803.89 Million | 3.14 Billion | 801.56 Million | 792.84 Million | 785.85 Million |
| Income Tax Expense | 212.03 Million | 168.61 Million | 315.9 Million | 192.51 Million | 101.02 Million | -74.42 Million |
| Earnings before Tax | 1.14 Billion | 969.77 Million | 587.92 Million | 782.01 Million | 100.12 Million | -1.56 Billion |
| Net Income | 932.32 Million | 702.02 Million | -1.24 Billion | 181.75 Million | 496.67 Million | -1.31 Billion |
| Earnings Per Share Basic | 10.14 | 7.64 | - | 1.98 | -0.49 | -14.54 |
| Earnings Per Share Diluted | 10.12 | 7.62 | - | 1.97 | -0.49 | -14.54 |
| Weighted Average Shares Outstanding | 91.94 Million | 91.91 Million | 91.46 Million | 91.46 Million | 91.46 Million | 90.33 Million |
| Weighted Average Shares Outstanding (Diluted) | 92.12 Million | 92.12 Million | 91.63 Million | 91.63 Million | 91.63 Million | 90.33 Million |
| Gross Margin | 0.59 | 0.37 | 0.36 | 0.39 | 0.59 | 0.58 |
| EBIT Margin | 0.21 | 0.20 | - | 0.21 | 0.15 | 0.15 |
| Profit Margin | 0.08 | 0.06 | -0.03 | 0.02 | 0.05 | -0.13 |
| EBITDA | 2.47 Billion | 2.16 Billion | - | 2.29 Billion | 1.58 Billion | 1.47 Billion |
| Earnings Before Tax Margin | 0.15 | 0.15 | 0.13 | 0.17 | 0.10 | 0.09 |
2459
6456
TVK
ASBFY
PEB
STMGF